They support how your skin functions
Injectable GHK-Cu has demonstrated systemic effects in animal models -- lung fibrosis protection, connective tissue remodeling, neuroprotection -- but translating those findings to human subcutaneous injection protocols remains speculative
The practical takeaway for a beginner is that these are two distinct compounds with two distinct research stories
KLOW Research Protocols and Working Concentrations Because KLOW is a fixed-ratio blend, research protocols are typically expressed as a total blend amount per administration in the model, which then breaks down proportionally across the four compounds (GHK-Cu making up roughly 62.5% of any given amount, with BPC-157, TB-500, and KPV each contributing 12.5%)
An LPS-free peptide indicates that Cagrilintide has been tested to confirm the absence of lipopolysaccharides, which are bacterial endotoxins that can interfere with experimental outcomes